Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Functional polymorphism in the neuropeptide Y gene promoter (rs16147) is associated with serum leptin levels and waist-hip ratio in women.

Mutschler J, Abbruzzese E, Wiedemann K, von der Goltz C, Dinter C, Mobascher A, Thiele H, Diaz-Lacava A, Dahmen N, Gallinat J, Majic T, Petrovsky N, Thuerauf N, Kornhuber J, Gründer G, Rademacher L, Brinkmeyer J, Wienker T, Wagner M, Winterer G, Kiefer F.

Ann Nutr Metab. 2013;62(4):271-6. doi: 10.1159/000346799. Epub 2013 May 4.

2.

Genetic variation in the neuropeptide Y gene promoter is associated with increased risk of tobacco smoking.

Mutschler J, Abbruzzese E, von der Goltz C, Dinter C, Mobascher A, Thiele H, Diaz-Lacava A, Dahmen N, Gallinat J, Majic T, Petrovsky N, Kornhuber J, Thuerauf N, Gründer G, Brinkmeyer J, Wienker T, Wagner M, Winterer G, Kiefer F.

Eur Addict Res. 2012;18(5):246-52. doi: 10.1159/000338276. Epub 2012 May 15.

3.

Polymorphisms in the neuropeptide Y gene and the risk of obesity: findings from two prospective cohorts.

Yeung EH, Zhang C, Chen J, Bowers K, Hu FB, Kang G, Qi L.

J Clin Endocrinol Metab. 2011 Dec;96(12):E2055-62. doi: 10.1210/jc.2011-0195. Epub 2011 Sep 21.

4.

Association of Neuropeptide Y Gene rs16147 Polymorphism with Cardiovascular Risk Factors, Adipokines, and Metabolic Syndrome in Patients with Obesity.

de Luis DA, Izaola O, de la Fuente B, Primo D, Aller R.

J Nutrigenet Nutrigenomics. 2016;9(5-6):213-221. doi: 10.1159/000452131. Epub 2016 Oct 28.

PMID:
27788523
5.

Influence of variants in the NPY gene on obesity and metabolic syndrome features in Spanish children.

Olza J, Gil-Campos M, Leis R, Rupérez AI, Tojo R, Cañete R, Gil A, Aguilera CM.

Peptides. 2013 Jul;45:22-7. doi: 10.1016/j.peptides.2013.04.007. Epub 2013 Apr 25.

PMID:
23624317
6.

Neuropeptide Y genotype, central obesity, and abdominal fat distribution: the POUNDS LOST trial.

Lin X, Qi Q, Zheng Y, Huang T, Lathrop M, Zelenika D, Bray GA, Sacks FM, Liang L, Qi L.

Am J Clin Nutr. 2015 Aug;102(2):514-9. doi: 10.3945/ajcn.115.107276. Epub 2015 Jul 8.

7.
8.

Polymorphism of neuropeptide Y gene rs16147 modifies the response to a hypocaloric diet on cardiovascular risk biomarkers and adipokines.

de Luis DA, Izaola O, de la Fuente B, Primo D, Aller R.

J Hum Nutr Diet. 2017 Apr;30(2):159-165. doi: 10.1111/jhn.12406. Epub 2016 Sep 7.

PMID:
27599771
9.

Polymorphism rs16147 of the Neuropeptide Y Gene Modifies the Response of Cardiovascular Risk Biomarkers and Adipokines to Two Hypocaloric Diets.

de Luis DA, Izaola O, Primo D, Aller R.

J Nutrigenet Nutrigenomics. 2017;10(1-2):63-72. doi: 10.1159/000478528. Epub 2017 Aug 5.

PMID:
28787737
10.

Influence of two polymorphisms of the tumoral necrosis factor-alpha gene on the obesity phenotype.

Corbalán MS, Marti A, Forga L, Patiño A, Martínez-Gonzalez MA, Martínez JA.

Diabetes Nutr Metab. 2004 Feb;17(1):17-22.

PMID:
15163120
11.

[Determination of insulin, leptin and neuropeptide y by radioimmunoanalysis in patients with morbid obesity and anorexia nervosa after therapeutic intervention].

Escobar L, Freire JM, Espinosa R, Pajares M, Girón JA, Vázquez JM, Chover A, Carrasco M, Ortero J, Gavilán I, Segura E, Aguilar M.

Rev Esp Med Nucl. 2002 Feb;21(1):3-11. Spanish.

12.

Adipocytokines, neuropeptide Y and insulin resistance in overweight women with gynoid and android type of adipose tissue distribution.

Orbetzova MM, Koleva DI, Mitkov MD, Atanassova IB, Nikolova JG, Atanassova PK, Genchev GD.

Folia Med (Plovdiv). 2012 Jul-Sep;54(3):22-9.

PMID:
23270203
13.

Increasing association between a neuropeptide Y promoter polymorphism and body mass index during the course of development.

Hohmann S, Buchmann AF, Witt SH, Rietschel M, Jennen-Steinmetz C, Schmidt MH, Esser G, Banaschewski T, Laucht M.

Pediatr Obes. 2012 Dec;7(6):453-60. doi: 10.1111/j.2047-6310.2012.00069.x. Epub 2012 Aug 31.

PMID:
22941950
14.

Comprehensive evaluation of the neuropeptide-Y gene variants in the risk of obesity: a case-control study and meta-analysis.

Zain SM, Mohamed Z, Jalaludin MY, Fauzi F, Hamidi A, Zaharan NL.

Pharmacogenet Genomics. 2015 Oct;25(10):501-10. doi: 10.1097/FPC.0000000000000164.

PMID:
26240981
15.

Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients.

Tiwari AK, Brandl EJ, Weber C, Likhodi O, Zai CC, Hahn MK, Lieberman JA, Meltzer HY, Kennedy JL, Müller DJ.

J Clin Psychopharmacol. 2013 Feb;33(1):11-7. doi: 10.1097/JCP.0b013e31827d145a.

PMID:
23277265
16.
17.

Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients.

Fernández-Real JM, Vendrell J, Ricart W, Broch M, Gutiérrez C, Casamitjana R, Oriola J, Richart C.

Diabetes Care. 2000 Jun;23(6):831-7.

18.

Polymorphisms in the NPY and AGRP genes and body fatness in Dutch adults.

van Rossum CT, Pijl H, Adan RA, Hoebee B, Seidell JC.

Int J Obes (Lond). 2006 Oct;30(10):1522-8. Epub 2006 Mar 28.

PMID:
16568137
19.

Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.

Pehlivanov B, Mitkov M.

Eur J Contracept Reprod Health Care. 2009 Apr;14(2):153-9. doi: 10.1080/13625180802549962.

PMID:
19340711
20.

Supplemental Content

Support Center